Prescription of Glucagon-Like Peptide 1 (GLP-1) in the Treatment of Patients With Type 2 Diabetes and Obesity: A Literature Review. Acervo Médico 2022, 11, e10289. https://doi.org/10.25248/reamed.e10289.2022.